- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Sorrento Therapeutics (NASDAQ:SRNE), Quotes and News Summary
Sorrento Therapeutics (NASDAQ: SRNE)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-05 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | ||||||
| REV | 18.385M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Sorrento Therapeutics Questions & Answers
You can purchase shares of Sorrento Therapeutics (NASDAQ: SRNE) through any online brokerage.
Other companies in Sorrento Therapeutics’s space includes: Avidity Biosciences (NASDAQ:RNA), Replimune Group (NASDAQ:REPL), FibroGen (NASDAQ:FGEN), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Alector (NASDAQ:ALEC).
The latest price target for Sorrento Therapeutics (NASDAQ: SRNE) was reported by HC Wainwright & Co. on Friday, March 25, 2022. The analyst firm set a price target for 20.00 expecting SRNE to rise to within 12 months (a possible 830.23% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Sorrento Therapeutics (NASDAQ: SRNE) is $2.15 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Sorrento Therapeutics.
Sorrento Therapeutics’s Q2 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Sorrento Therapeutics.
Sorrento Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.